Certis Oncology Solutions Launches CertisAI™ Platform to Enhance Drug Response Predictions with AI/ML Technology.

Certis Oncology Solutions has launched its CertisAI™ Predictive Oncology Intelligence platform, aimed at providing biopharmaceutical companies with advanced AI/ML tools to improve drug efficacy studies and clinical trial patient enrollment. The platform utilizes data-driven insights to support decision-making in early drug development.